FFO
CPRX icon

Fortitude Family Office’s Catalyst Pharmaceutical CPRX Stock Holding History

Fortitude Family Office’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.63K Hold
106
– – ﹤0.01% 1184
2025
Q4 		$2.47K Hold
106
– – ﹤0.01% 1088
2025
Q3 		$2.09K Hold
106
– – ﹤0.01% 1200
2025
Q2 		$2.3K Sell
106
-11
-9% -$260 ﹤0.01% 1125
2025
Q1 		$2.84K Hold
117
– – ﹤0.01% 858
2024
Q4 		$2.44K Hold
117
– – ﹤0.01% 1002
2024
Q3 		$2.33K Hold
117
– – ﹤0.01% 973
2024
Q2 		$1.81K Hold
117
– – ﹤0.01% 817
2024
Q1 		$1.86K Hold
117
– – ﹤0.01% 833
2023
Q4 		$1.97K Buy
+117
New +$1.6K ﹤0.01% 872

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM